199 related articles for article (PubMed ID: 34409916)
1. Continuation of outpatient buprenorphine therapy after dispensing Buprenorphine-Naloxone from the emergency department.
Krenz JR; Hayes BD; Wakeman SE; Martin A; Raja AS; White BA; Koehl JL
Clin Toxicol (Phila); 2022 Apr; 60(4):429-432. PubMed ID: 34409916
[TBL] [Abstract][Full Text] [Related]
2. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
Hu T; Snider-Adler M; Nijmeh L; Pyle A
CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
[TBL] [Abstract][Full Text] [Related]
4. Multi-site intervention to improve emergency department care for patients who live with opioid use disorder: A quantitative evaluation.
McLane P; Scott K; Suleman Z; Yee K; Holroyd BR; Dong K; Ghosh SM; Fanaeian J; Deol J; Biggs C; Lang E; ; Hair H; Ross M; Tanguay R; Olmstead A; Fisher A; Fielding S
CJEM; 2020 Nov; 22(6):784-792. PubMed ID: 32924911
[TBL] [Abstract][Full Text] [Related]
5. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
[TBL] [Abstract][Full Text] [Related]
6. Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation.
Sun T; Aroke H; Kogut S; Katenka N; Bratberg J; Buchanan A
Am J Drug Alcohol Abuse; 2022 Mar; 48(2):217-225. PubMed ID: 34780312
[No Abstract] [Full Text] [Related]
7. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments.
Stone KD; Scott K; Holroyd BR; Lang E; Yee K; Taghizadeh N; Deol J; Dong K; Fanaeian J; Ghosh M; Low K; Ross M; Tanguay R; Faris P; Day N; McLane P
CJEM; 2023 Jul; 25(7):598-607. PubMed ID: 37245202
[TBL] [Abstract][Full Text] [Related]
9. The use of buprenorphine to-go packs in the emergency department.
Zimmerman DE; Johnson B; Kearns A; Metro H; Robb A; Nemecek BD; Montepara CA; Covvey JR; Lynch MJ
Am J Emerg Med; 2024 Mar; 77():154-157. PubMed ID: 38150985
[TBL] [Abstract][Full Text] [Related]
10. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
[TBL] [Abstract][Full Text] [Related]
11. Linking MATTERS: Barriers and Facilitators to Implementing Emergency Department-Initiated Buprenorphine-Naloxone in Patients with Opioid Use Disorder and Linkage to Long-Term Care.
Sokol R; Tammaro E; Kim JY; Stopka TJ
Subst Use Misuse; 2021; 56(7):1045-1053. PubMed ID: 33825669
[TBL] [Abstract][Full Text] [Related]
12. Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs.
Duncan K; Scheuermeyer F; Lane D; Ahamad K; Moe J; Dong K; Nolan S; Buxton J; Miles I; Johnson C; Christenson J; Whyte M; Daoust R; Garrod E; Badke K; Kestler A
CJEM; 2023 Oct; 25(10):802-807. PubMed ID: 37606738
[TBL] [Abstract][Full Text] [Related]
13. Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study.
Badke K; Small SS; Pratt M; Lockington J; Gurney L; Kestler A; Moe J
BMC Health Serv Res; 2024 Feb; 24(1):211. PubMed ID: 38360620
[TBL] [Abstract][Full Text] [Related]
14. Sustained Implementation of a Multicomponent Strategy to Increase Emergency Department-Initiated Interventions for Opioid Use Disorder.
Lowenstein M; Perrone J; Xiong RA; Snider CK; O'Donnell N; Hermann D; Rosin R; Dees J; McFadden R; Khatri U; Meisel ZF; Mitra N; Delgado MK
Ann Emerg Med; 2022 Mar; 79(3):237-248. PubMed ID: 34922776
[TBL] [Abstract][Full Text] [Related]
15. Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management.
Sidlak A; Dibble B; Dhaliwal M; Bottone P; Marino R; Henry L; Howell J
Drug Alcohol Depend; 2024 May; 258():111136. PubMed ID: 38518662
[TBL] [Abstract][Full Text] [Related]
16. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.
Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA
Am J Emerg Med; 2021 Dec; 50():409-412. PubMed ID: 34481260
[TBL] [Abstract][Full Text] [Related]
17. The Impact of a Peer-Navigator Program on Naloxone Distribution and Buprenorphine Utilization in the Emergency Department.
Ramdin C; Guo M; Fabricant S; Santos C; Nelson L
Subst Use Misuse; 2022; 57(4):581-587. PubMed ID: 34970942
[No Abstract] [Full Text] [Related]
18. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
[TBL] [Abstract][Full Text] [Related]
20. The association of Medicare Part D prior authorization for buprenorphine-naloxone with adherence to opioid use disorder treatment guidelines in the United States.
Parish WJ; Mark TL; Zarkin GA; Weber E
Addiction; 2022 Jan; 117(1):141-150. PubMed ID: 34033177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
